» Articles » PMID: 26756635

Glucose Transporters in Cardiac Metabolism and Hypertrophy

Overview
Journal Compr Physiol
Specialty Physiology
Date 2016 Jan 13
PMID 26756635
Citations 128
Authors
Affiliations
Soon will be listed here.
Abstract

The heart is adapted to utilize all classes of substrates to meet the high-energy demand, and it tightly regulates its substrate utilization in response to environmental changes. Although fatty acids are known as the predominant fuel for the adult heart at resting stage, the heart switches its substrate preference toward glucose during stress conditions such as ischemia and pathological hypertrophy. Notably, increasing evidence suggests that the loss of metabolic flexibility associated with increased reliance on glucose utilization contribute to the development of cardiac dysfunction. The changes in glucose metabolism in hypertrophied hearts include altered glucose transport and increased glycolysis. Despite the role of glucose as an energy source, changes in other nonenergy producing pathways related to glucose metabolism, such as hexosamine biosynthetic pathway and pentose phosphate pathway, are also observed in the diseased hearts. This article summarizes the current knowledge regarding the regulation of glucose transporter expression and translocation in the heart during physiological and pathological conditions. It also discusses the signaling mechanisms governing glucose uptake in cardiomyocytes, as well as the changes of cardiac glucose metabolism under disease conditions.

Citing Articles

Ontogeny of Fetal Cardiometabolic Pathways: The Potential Role of Cortisol and Thyroid Hormones in Driving the Transition from Preterm to Near-Term Heart Development in Sheep.

Amanollahi R, Holman S, Bertossa M, Meakin A, Thornburg K, McMillen I J Cardiovasc Dev Dis. 2025; 12(2).

PMID: 39997470 PMC: 11856455. DOI: 10.3390/jcdd12020036.


Cardiac growth patterns and metabolism before and after birth in swine: Role of miR in proliferation, hypertrophy and metabolism.

Dimasi C, Darby J, Holman S, Quinn M, Meakin A, Seed M J Mol Cell Cardiol Plus. 2025; 9():100084.

PMID: 39803591 PMC: 11708124. DOI: 10.1016/j.jmccpl.2024.100084.


Induction on Insulin Resistance In Vitro.

Saw E Methods Mol Biol. 2024; 2894:43-51.

PMID: 39699809 DOI: 10.1007/978-1-0716-4342-6_5.


Exploring the Interplay between the Warburg Effect and Glucolipotoxicity in Cancer Development: A Novel Perspective on Cancer Etiology.

Akl M, Ahmed A Adv Pharm Bull. 2024; 14(3):705-713.

PMID: 39494260 PMC: 11530886. DOI: 10.34172/apb.2024.049.


Computational approaches to investigate the relationship between periodontitis and cardiovascular diseases for precision medicine.

Duenas S, McGee Z, Mhatre I, Mayilvahanan K, Patel K, Abdelhalim H Hum Genomics. 2024; 18(1):116.

PMID: 39427205 PMC: 11491019. DOI: 10.1186/s40246-024-00685-7.


References
1.
Jain M, Cui L, Brenner D, Wang B, Handy D, Leopold J . Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase. Circulation. 2004; 109(7):898-903. DOI: 10.1161/01.CIR.0000112605.43318.CA. View

2.
PATERNOSTRO G, Clarke K, Heath J, SEYMOUR A, Radda G . Decreased GLUT-4 mRNA content and insulin-sensitive deoxyglucose uptake show insulin resistance in the hypertensive rat heart. Cardiovasc Res. 1995; 30(2):205-11. View

3.
Finck B, Lehman J, Leone T, Welch M, Bennett M, Kovacs A . The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest. 2002; 109(1):121-30. PMC: 150824. DOI: 10.1172/JCI14080. View

4.
Hue L, Rider M . Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Biochem J. 1987; 245(2):313-24. PMC: 1148124. DOI: 10.1042/bj2450313. View

5.
Hall J, Sexton W, Stanley W . Exercise training attenuates the reduction in myocardial GLUT-4 in diabetic rats. J Appl Physiol (1985). 1995; 78(1):76-81. DOI: 10.1152/jappl.1995.78.1.76. View